Papaya improves non-alcoholic fatty liver disease in obese rats by attenuating oxidative stress, inflammation and lipogenic gene expression

被引:1
|
作者
Wanwisa Deenin [1 ]
Wachirawadee Malakul [1 ]
Tantip Boonsong [2 ]
Ittipon Phoungpetchara [3 ]
Sakara Tunsophon [1 ,4 ]
机构
[1] Department of Physiology, Faculty of Medical Science, Naresuan University
[2] Department of Biochemistry, Faculty of Medical Science, Naresuan University
[3] Department of Anatomy, Faculty of Medical Science, Naresuan University
[4] Centre of Excellence for Innovation in Chemistry, Naresuan University
关键词
D O I
暂无
中图分类号
R575.5 [肝代谢障碍];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Non-alcoholic fatty liver disease(NAFLD) is a global health issue that is correlated with obesity and oxidative stress.AIM To evaluate the anti-NAFLD effect of papaya in high fat diet induced obesity in rats.METHODS Four-week-old male Sprague-Dawley rats were divided into four groups after 1 wk of acclimatization: Group 1 was the rats fed a normal diet(C); group 2 was the rats fed a high fat diet(HFD); group 3 was the rats fed a HFD with 0.5 m L of papaya juice/100 g body weight(HFL), and group 4 was the rats fed a HFD with 1 m L of papaya juice/100 g body weight(HFH) for 12 wk. At the end of the treatment, blood and tissue samples were collected for biochemical analyses and histological assessment.RESULTS The results of the HFH group showed significantly reduced body weight(HFH vs HFD, P < 0.01), decreased NAFLD score(HFH vs HFD, P < 0.05), and reduced hepatic total cholesterol(HFL vs HFD, P < 0.01; HFH vs HFD, P < 0.001), hepatic triglyceride(HFH vs HFD, P < 0.05), malondialdehyde(HFL, HFH vs HFD, P < 0.001), tumour necrosis factor-α(HFH vs HFD, P < 0.05) and interleukin-6(HFH vs HFD, P < 0.05) when compared to the HFD group. However, the liver weight showed no significant difference among the groups. The activities of catalase and superoxide dismutase significantly increased in HFH when compared with the HFD group(P < 0.05 and P < 0.001, respectively). The suppression of transcriptional factors of hepatic lipogenesis, including sterol regulatory elementbinding protein 1 c and fatty acid synthase, were observed in the papaya treated group(HFH vs HFD, P < 0.05). These beneficial effects of papaya against HFDinduced NAFLD are through lowering hepatic lipid accumulation, suppressing the lipogenic pathway, improving the balance of antioxidant status, and lowering systemic inflammation.CONCLUSION These current results provide experimental-based evidence suggesting papaya is an efficacious medicinal fruit for use in the prevention or treatment of NAFLD.
引用
收藏
页码:315 / 327
页数:13
相关论文
共 50 条
  • [1] Papaya improves non-alcoholic fatty liver disease in obese rats by attenuating oxidative stress, inflammation and lipogenic gene expression
    Deenin, Wanwisa
    Malakul, Wachirawadee
    Boonsong, Tantip
    Phoungpetchara, Ittipon
    Tunsophon, Sakara
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (03) : 315 - 327
  • [2] Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation
    Noori, Maryam
    Jafari, Bahar
    Hekmatdoost, Azita
    JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2017, 97 (08) : 2327 - 2332
  • [3] Oxidative Stress in Non-Alcoholic Fatty Liver Disease
    Smirne, Carlo
    Croce, Eleonora
    Di Benedetto, Davide
    Cantaluppi, Vincenzo
    Comi, Cristoforo
    Sainaghi, Pier Paolo
    Minisini, Rosalba
    Grossini, Elena
    Pirisi, Mario
    LIVERS, 2022, 2 (01): : 30 - 76
  • [4] Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development
    Li, Yan
    Hai, Jie
    Li, Lake
    Chen, Xuehui
    Peng, Hua
    Cao, Meng
    Zhang, Qinggui
    ENDOCRINE, 2013, 43 (02) : 376 - 386
  • [5] Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development
    Yan Li
    Jie Hai
    Lake Li
    Xuehui Chen
    Hua Peng
    Meng Cao
    Qinggui Zhang
    Endocrine, 2013, 43 : 376 - 386
  • [6] Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease-Oxidative Stress and Inflammation Relevance
    Robea, Madalina Andreea
    Balmus, Ioana-Miruna
    Girleanu, Irina
    Huiban, Laura
    Muzica, Cristina
    Ciobica, Alin
    Stanciu, Carol
    Cimpoesu, Carmen Diana
    Trifan, Anca
    MEDICINA-LITHUANIA, 2023, 59 (09):
  • [7] Oxidative stress parameters in paediatric non-alcoholic fatty liver disease
    Nobili, Valerio
    Parola, Maurizio
    Alisi, Anna
    Marra, Fabio
    Piemonte, Fiorella
    Mombello, Cristina
    Sutti, Salvatore
    Povero, Davide
    Maina, Virginia
    Novo, Erica
    Albano, Emanuele
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 (04) : 471 - 476
  • [8] Oxidative stress in alcoholic and non-alcoholic liver disease
    Cortez-Pinto, H
    STEATOHEPATITIS (NASH AND ASH), 2001, 121 : 54 - 61
  • [9] Blood oxidative stress related parameters in alcoholic liver disease and non-alcoholic fatty liver disease
    Das, Subir Kumar
    Balakrishnan, V.
    Mukherjee, Sukhes
    Vasudevan, D. M.
    PROCEEDINGS OF THE 3RD BIENNIAL MEETING OF THE SOCIETY FOR FREE RADICAL RESEARCH - ASIA & 6TH ANNUAL MEETING OF THE SOCIETY FOR FREE RADICAL RESEARCH - INDIA, 2007, : 11 - +
  • [10] Losartan Improves Hepatic Inflammation in Children With Non-Alcoholic Fatty Liver Disease
    Vos, Miriam
    Jin, Ran
    Welsh, Jean
    Konomi, Juna
    Karpen, Saul J.
    Soler-Rodriquez, Dellys
    Cleeton, Rebecca L.
    Jones, Dean
    GASTROENTEROLOGY, 2016, 150 (04) : S1036 - S1036